Showing results (1681-1690 of 2,090) with videos related to

Sort By:
Pageof 209
Journal of Pediatric Urology|December 3, 2024
Adherence to follow-up ten years after hypospadias repairNikhil V Batra, Joshua Heiman, Jeremy Koehlinger, et al.
Journal of the American College of Cardiology|June 30, 2018
Acute Cardiac Effects of Severe Pre-EclampsiaArthur Jason Vaught, Lara C Kovell, Linda M Szymanski, et al.
Vaccine|April 1, 1997
Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 micrograms liquid formulation: a comparison of three lots with the 15.0 micrograms lyophilized formulation. Study Group for 7.5 micrograms Liquid PedvaxHIBP M Mendelman, L Feeley, S Bird, et al.
European Heart Journal|July 16, 2013
Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international studyJean-François Avierinos, Christophe Tribouilloy, Francesco Grigioni, et al.
Archives of Virology|July 25, 2013
A suggested classification for two groups of Campylobacter myovirusesMuhammad Afzal Javed, Hans-Wolfgang Ackermann, Joana Azeredo, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 16, 2025
Safety of Transesophageal Echocardiography in Patients Referred for Tricuspid Valve Disease at a Center for Structural Heart DiseaseAndrew Chou, Monique Oye, Krishna Modi, et al.
Wiener Klinische Wochenschrift|November 20, 2013
[Vaccination recommendations for health care workers in Austria]Ursula Wiedermann, Pamela Rendi-Wagner, Gerhard Aigner, et al.
Annals of Hematology|April 19, 2017
Impact of cachexia on outcomes in aggressive lymphomasReem Karmali, Taha Alrifai, Ibtihaj A M Fughhi, et al.
Circulation|September 14, 2013
Late repair of ischemic mitral regurgitation does not prevent left ventricular remodeling: importance of timing for beneficial repairJonathan Beaudoin, Robert A Levine, J Luis Guerrero, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Pageof 209